Sign In

Michael J. Silverberg, PhD, MPH

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3801 (phone)
michael.j.silverberg@kp.org
Kaiser Permanente Researcher Profiles


 
Michael J. Silverberg, PhD, MPH, has been a research scientist at the Division of Research, Kaiser Permanente Northern California since 2004. He received his doctorate in epidemiology from the Johns Hopkins University, Bloomberg School of Public Health in 2001, and his master’s in public health in epidemiology from the School of Public Health, University of California, Los Angeles in 1999.

Current Position(s):

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California

Section Affiliations:

Primary Research Interests:

  • HIV and aging
  • Infectious disease epidemiology
  • Cervical cancer screening and outcomes
  • Treatment and outcomes of viral hepatitis

    Safety of Direct-Acting Antiviral Medications for Hepatitis C

    This project will identify all patients who have a laboratory-confirmed diagnosis of Hepatitis C. The intervention group will be those who had a prescription filled for a new antiviral medication after October 10, 2014, and who were naive to treatment for Hep C prior to the prescription. The comparison group will be those who have not been treated for Hep C. Incidence of the following types of adverse events will be measured: acute or acute-on-chronic or uncertain cause liver failure (including liver transplant), acute kidney failure, myocardial infarction, liver cancer, multiple organ failure, stroke, and death. For liver failure in particular, a chart review will be conducted to validate the outcome. The initial analysis will use a Poisson model that includes exposure time (time to adverse event or censoring event). Other analytic methods may be employed to address channeling by indication.
    Investigator: Silverberg, Michael
    Funder: Patient-Centered Outcomes Research Institute

    HIV Infection, Use of Tenofovir and Other Antiretrovirals, and Risk of Fatal and Non-Fatal Comorbidities: Cohort Study in Kaiser Permanente

    Although the benefits of combination antiretroviral therapy (ART) for reducing HIV-related morbidity and mortality are well-recognized, toxicity from some ART may potentially contribute to excess age-related comorbidities. Certain antiretrovirals, including tenofovir, have known renal toxicity, but recent formulations may be associated with improved outcomes. Tenofovir-based ART is also increasingly used in high-risk HIV-uninfected individuals for HIV preexposure prophylaxis (PrEP), although the long-term health outcomes are unknown. The goal of this study is to characterize the incidence and predictors of key fatal and non-fatal comorbidities in HIV patients, and in demographically similar comparison groups of HIV-uninfected patients, including a general population sample, and HIV-uninfected individuals prescribed PrEP. This research will be conducted in approximately 39,000 HIV-infected and 390,000 HIV-uninfected subjects from Kaiser Permanente Northern California, Kaiser Permanente Southern California, and Kaiser Permanente of the Mid-Atlantic States.
    Investigator: Silverberg, Michael
    Funder: Gilead Sciences, Inc.

    Safety of Direct Acting Antiviral Medications for Hepatitis C

    This project will identify all patients who have a laboratory-confirmed diagnosis of Hepatitis C. The intervention group will be those who had a prescription filled for a new antiviral medication after October 10, 2014, and who were naive to treatment for Hep C prior to the prescription. The comparison group will be those who have not been treated for Hep C. Incidence of the following types of adverse events will be measured: acute or acute-on-chronic or uncertain cause liver failure (including liver transplant), acute kidney failure, myocardial infarction, liver cancer, multiple organ failure, stroke, and death. For liver failure in particular, a chart review will be conducted to validate the outcome. The initial analysis will use a Poisson model that includes exposure time (time to adverse event or censoring event). Other analytic methods may be employed to address channeling by indication.
    Investigator: Silverberg, Michael
    Funder: Patient-Centered Outcomes Research Institute

    Safety of Direct-Acting Antiviral Medications for Hepatitis C

    This study will investigate the safety of direct-acting antiviral medications in patients who have a laboratory-confirmed diagnosis of hepatitis C. The intervention group will be those who had a prescription filled for a new antiviral medication after October 10, 2014. The comparison group will be those who have not been treated for hepatitis C. Incidence of the following types of adverse events will be measured: acute or acute-on-chronic or uncertain-cause liver failure (including liver transplant), acute kidney failure, myocardial infarction, liver cancer, multiple organ failure, stroke, and death. For liver failure in particular, a chart review will be conducted to validate the outcome. Initial analysis will use a Poisson model that includes exposure time (time to adverse event or censoring event). Other analytic methods may be employed to address channeling by indication.
    Investigator: Silverberg, Michael
    Funder: Patient-Centered Outcomes Research Institute

    Extension of the Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance (COMpAAAS)

    With support from the National Institute on Alcohol Abuse and Alcoholism, the Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance (COMpAAAS) has analyzed data from patients in the Veterans Administration Cohort Study. This project seeks to extend this consortium to include Kaiser Permanente and the antiretroviral therapy cohort collaboration at the University of Bristol as new partners to increase sample diversity and representation of people living with HIV. The primary goals of the study are to evaluate the risk of alcohol and tobacco exposure on mortality, hospitalizations, comorbidities, and physiologic frailty for people living with HIV and matched HIV-uninfected controls. Each of the collaborating sites will share aims and study protocols, and will coordinate data management, statistical analysis, and reporting of results to increase sample size, include diverse populations, enhance comparability and generalizability, and maximize impact, as well as utilize resources efficiently.
    Investigator: Satre, Derek; Silverberg, Michael
    Funder: National Institute on Alcohol Abuse and Alcoholism

    Optimizing Lung Cancer Treatment in HIV Infected Persons

    Lung cancer is now a leading cause of death in HIV infected persons. Lung cancer survival is worse in HIV infected persons, in part due to uncertainty regarding the optimal treatment pathways for this group. In this project we will use data from several large, representative HIV cohorts to calibrate a well-validated, biologically-based simulation model of lung cancer (the Lung Cancer Policy Model) to determine the lung cancer treatments that offer the best life expectancy and quality-of-life for HIV infected lung cancer patients.
    Investigator: Silverberg, Michael
    Funder: National Cancer Institute

    Effectiveness and safety of interferon-free treatment for hepatitis C virus (HCV) infection in a clinical practice setting

    This a cohort study of KPNC patients initiating interferon-free treatment for HCV infection, with the following specific aims: 1) Determine the short- and long-term effectiveness of interferon-free treatment for HCV infection, 2) determine the safety of interferon-free treatment for HCV infection, and 3) compare the effectiveness and safety of 8- versus 12-week interferon-free treatment for HCV infection. Our results will guide clinical decision-making to maximize the effectiveness and safety of HCV treatment for KPNC patients.
    Investigator: Silverberg, Michael
    Funder: The Permanente Medical Group

    Optimizing Cardiovascular Risk Prediction in HIV

    The objective of this study is to develop methods to accurately predict cardiovascular disease (CVD) risk for HIV patients. CVD risk is increased for HIV patients, yet accurate methods for risk prediction remain unclear. We will evaluate the performance of the Framingham Risk Score (FRS) and the ACC/AHA risk prediction algorithm among HIV patients and generate new CVD risk prediction algorithms incorporating HIV and HIV-related factors to assess whether risk prediction can be improved for this population. The HIV-specific CVD risk prediction algorithms will be generated in collaboration with Framingham Heart Study investigators using an HIV clinical care cohort from the Partners HealthCare System and will be externally validated using the Kaiser Permanente Northern California (KPNC) HIV cohort. The ability to accurately risk-stratify HIV patients will ensure that the highest risk patients receive appropriate treatment and will directly impact long-term HIV care strategies.
    Investigator: Silverberg, Michael
    Funder: National Heart, Lung, and Blood Institute

    HIV Status and Incidence and Outcomes of Heart Failure

    Antiretroviral therapy (ART) has prolonged the lifespan of HIV-infected patients, resulting in a growing number of individuals aging with HIV infection. As this population ages, comorbidities, such as cardiovascular disease have increasingly contributed to excess morbidity and mortality. Unlike acute myocardial infarction, heart failure incidence is increasing in the general population, with associated serious morbidity and excess mortality, but has received less attention in the HIV population. Leveraging the Cardiovascular Research Network's Heart Failure consortium, our study goals are: 1) To characterize the association of HIV status with the incidence of heart failure; 2) Among HIV-infected patients, to evaluate the effect of ART use, CD4 and HIV viral replication on the incidence of heart failure; and 3) To examine the influence of HIV status on heart failure-related treatment patterns, hospitalizations and death among incident heart failure patients.
    Investigator: Silverberg, Michael
    Funder: National Heart, Lung, and Blood Institute

    HPV Vaccine Impact Study

    The California Emerging Infections Program will collaborate with the California Department of Health Services to develop a comprehensive plan to conduct systematic population-based cervical intraepithelial neoplasia surveillance and implement a pilot project in Alameda County. This population-based surveillance project aims to monitor the impact of the HPV vaccine on cervical cancer precursor lesions.
    Investigator: Silverberg, Michael
    Funder: Centers for Disease Control and Prevention

    HIV Drug Resistance Mutation as Predictors of Clinical Outcome

    In collaboration with KPNC clinicians and investigators, Stanford performs research investigations regarding the relationship of HIV resistance, antiretroviral therapy and clinical outcomes, including CD4 and HIV RNA response.
    Investigator: Silverberg, Michael
    Funder: Stanford University

    Implementing Computerized Substance Use and Depression Screening and Evidence-Based Treatments in an HIV Primary Care Population

    This proposal will develop and test the delivery of integrated, sustainable, evidence-based interventions to improve health outcomes of people living with HIV with substance use disorders (SUDs). The intervention will be delivered in advance of routine health care visits, and aims to systematize SUD screening aided by use of patient portals, within several large HIV clinics in KPNC. Outcomes of interest include ongoing substance use, linkage with primary-care-based SUD-services, antiretroviral therapy adherence and response, and comorbidities linked to both SU and HIV.
    Investigator: Silverberg, Michael
    Funder: National Institute on Drug Abuse

    Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons

    The overarching goal of this study is to formulate evidence-based recommendations about the preferred CD4 T-cell count at which to initiate antiretroviral therapy (ART), and the preferred initial ART regimen, that would minimize cancer incidence among HIV-infected persons.
    Investigator: Silverberg, Michael
    Funder: National Cancer Institute

    Using Comparative Effectiveness Analyses to Optimize Cervical Cancer Screening

    The overall goal of this study is to identify optimal cervical cancer screening strategies that minimize associated screening harms, while maximizing benefits. The approach will use decision analytic models and comparative effectiveness analyses to identify novel screening strategies that provide similar benefits and harms, resulting in a range of options for cervical cancer screening, which might vary by individual risk factors.
    Investigator: Silverberg, Michael
    Funder: National Cancer Institute

    North America AIDS Cohorts Collaboration on Research and Design (NA-ACCORD)

    The NA-ACCORD is a consortium of HIV cohorts across U.S. and Canada endeavoring to address major HIV-related clinical and epidemiologic questions that cannot be addressed through smaller studies. Dr. Silverberg is leading the HIV and Cancer research efforts in NA-ACCORD.
    Investigator: Silverberg, Michael
    Funder: National Institute of Allergy and Infectious Diseases
    No results found matching criteria

    Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort

    Author(s): Kamineni A; Silverberg MJ; Corley DA; PROSPR consortium; et al.

    Int J Cancer. 2018 Oct 24.

    PubMed abstract

    Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California

    Author(s): Marcus JL; Hurley LB; Dentoni-Lasofsky D; Ellis CG; Silverberg MJ; Slome S; Snowden JM; Volk JE

    AIDS Care. 2018 Oct 10:1-9.

    PubMed abstract

    Agreement between medical records and self-reports: Implications for transgender health research

    Author(s): Gerth J; Becerra-Culqui T; Bradlyn A; Getahun D; Hunkeler EM; Lash TL; Millman A; Nash R; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M

    Rev Endocr Metab Disord. 2018 Sep 15.

    PubMed abstract

    Reduced cancer survival among adults with HIV and an AIDS-defining illnesses despite no difference in cancer stage at diagnosis

    Author(s): Grover S; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design; et al.

    J Acquir Immune Defic Syndr. 2018 Sep 05.

    PubMed abstract

    Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals

    Author(s): Marcus JL; Hurley LB; Prasad A; Zaroff J; Klein DB; Horberg MA; Go AS; DeLorenze GN; Quesenberry CP; Sidney S; Lo JC; Silverberg MJ

    HIV Med. 2018 Sep 04.

    PubMed abstract

    One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States.

    Author(s): Desir FA; Silverberg M; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Region of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium; et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Aug 31;():. Epub 2018-08-31.

    PubMed abstract

    Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

    Author(s): Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF

    Lancet Child Adolesc Health. 2018 Oct;2(10):707-714. Epub 2018-08-08.

    PubMed abstract

    Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients

    Author(s): Lam JO; Barnell GM; Merchant M; Ellis CG; Silverberg MJ

    HIV Med. 2018 Aug 06.

    PubMed abstract

    Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.

    Author(s): Getahun, Darios D; Nash, Rebecca R; Flanders, W Dana WD; Baird, Tisha C TC; Becerra-Culqui, Tracy A TA; Cromwell, Lee L; Hunkeler, Enid E; Lash, Timothy L TL; Millman, Andrea A; Quinn, Virginia P VP; Robinson, Brandi B; Roblin, Douglas D; Silverberg, Michael J MJ; Safer, Joshua J; Slovis, Jennifer J; Tangpricha, Vin V; Goodman, Michael M

    Annals of internal medicine. 2018 Aug 21;169(4):205-213. Epub 2018-07-10.

    PubMed abstract

    Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men

    Author(s): Burger EA; Dyer MA; Sy S; Palefsky JM; De Pokomandy A; Coutlee F; Silverberg MJ; Kim JJ

    J Acquir Immune Defic Syndr. 2018 May 09.

    PubMed abstract

    Cutaneous Melanoma Risk among People with HIV in the United States and Canada

    Author(s): Yanik EL; Leyden W; Neugebauer RS; Silverberg MJ; Dubrow R; et al.

    J Acquir Immune Defic Syndr. 2018 Apr 27.

    PubMed abstract

    Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ ≥ 500: a simulation study

    Author(s): Kong CY; Silverberg MJ; Crothers K; et al.

    AIDS. 2018 Apr 19.

    PubMed abstract

    Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer

    Author(s): Averbach S; Silverberg MJ; Leyden W; Smith-McCune K; Raine-Bennett T; Sawaya GF

    Contraception. 2018 Apr 16.

    PubMed abstract

    Mental Health of Transgender and Gender Nonconforming Youth Compared With Their Peers

    Author(s): Becerra-Culqui TA; Cromwell L; Hunkeler EM; Millman A; Robinson B; Silverberg MJ; Goodman M; et al.

    Pediatrics. 2018 Apr 16.

    PubMed abstract

    Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study

    Author(s): Silverberg MJ; Leibowitz A; Jang HJ; Sterling S; Parthasarathy S; Satre DD; et al.

    Addict Behav. 2018 Mar 31;84:110-117. Epub 2018-03-31.

    PubMed abstract

    Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals

    Author(s): Owen-Smith AA; Hunkeler E; Millman A; Silverberg MJ; Goodman M et al.

    J Sex Med. 2018 Feb 17.

    PubMed abstract

    Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV

    Author(s): Elion RA; Silverberg MJ; Palella FJ; North American AIDS Cohort Collaboration on Research and Design of IeDEA et al.

    J Acquir Immune Defic Syndr. 2018 Feb 06.

    PubMed abstract

    Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia

    Author(s): Silverberg MJ; Leyden WA; Chi A; Gregorich S; Huchko MJ; Kulasingam S; Kuppermann M; Seto A; Smith-McCune KK; Sawaya GF

    Obstet Gynecol. 2018 Jan;131(1):47-55.

    PubMed abstract

    Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.

    Author(s): Marcus JL; Lam JO; Quesenberry CP; Silverberg MJ; et al.

    Public health reports (Washington, D.C. : 1974). 2018 Jan 01;():33354918772059. Epub 2018-01-01.

    PubMed abstract

    Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people.

    Author(s): Quinn VP; Nash R; Hunkeler E; Contreras R; Cromwell L; Becerra-Culqui TA; Getahun D; Giammattei S; Lash TL; Millman A; Robinson B; Roblin D; Silverberg MJ; Slovis J; Tangpricha V; Tolsma D; Valentine C; Ward K; Winter S; Goodman M

    BMJ open. 2017 12 27;7(12):e018121. Epub 2017-12-27.

    PubMed abstract

    Cancer burden attributable to cigarette smoking among HIV-infected people in North America

    Author(s): Altekruse SF; Shiels MS; Modur SP; Land SR; Crothers KA; Kitahata MM; Thorne JE; Mathews WC; Fernández-Santos DM; Mayor AM; Gill JM; Horberg MA; Brooks JT; Moore RD; Silverberg MJ; Althoff KN; Engels EA

    AIDS. 2017 Dec 12.

    PubMed abstract

    Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

    Author(s): Clutter DS; Zhou S; Varghese V; Rhee SY; Pinsky BA; Jeffrey Fessel W; Klein DB; Spielvogel E; Holmes SP; Hurley LB; Silverberg MJ; Swanstrom R; Shafer RW

    J Infect Dis. 2017 Aug 01;216(3):387-391.

    PubMed abstract

    Redefining HIV Preexposure Prophylaxis Failures

    Author(s): Marcus JL; Hurley LB; Nguyen DP; Silverberg MJ; Volk JE

    Clin Infect Dis. 2017 Jul 29.

    PubMed abstract

    Cohort study of cancer risk among insured transgender people

    Author(s): Silverberg MJ; Nash R; Becerra-Culqui TA; Cromwell L; Getahun D; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Slovis J; Tangpricha V; Goodman M

    Ann Epidemiol. 2017 Jul 22.

    PubMed abstract

    Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load

    Author(s): Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ

    JAMA Dermatol. 2017 Jul 12.

    PubMed abstract

    Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study

    Author(s): Storholm ED; Volk JE; Marcus JL; Silverberg MJ; Satre DD

    Prev Sci. 2017 Jun 03.

    PubMed abstract

    Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population

    Author(s): Drozd DR; Kitahata MM; Althoff KN; Zhang J; Gange SJ; Napravnik S; Burkholder GA; Mathews WC; Silverberg MJ; Sterling TR; Heckbert SR; Budoff MJ; Van Rompaey S; Delaney JAC; Wong C; Tong W; Palella FJ; Elion RA; Martin JN; Brooks JT; Jacobson LP; Eron JJ; Justice AC; Freiberg MS; Klein DB; Post WS; Saag MS; Moore RD; Crane HM

    J Acquir Immune Defic Syndr. 2017 May 17.

    PubMed abstract

    Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors

    Author(s): Muzaale AD; Althoff KN; Sperati CJ; Abraham AG; Kucirka LM; Massie AB; Kitahata MM; Horberg MA; Justice AC; Fischer MJ; Silverberg MJ; Butt AA; Boswell SL; Rachlis AR; Mayor AM; Gill MJ; Eron JJ; Napravnik S; Drozd DR; Martin JN; Bosch RJ; Durand CM; Locke JE; Moore RD; Lucas GM; Segev DL

    Am J Transplant. 2017 May 12.

    PubMed abstract

    A Flow-Based Model of the HIV Care Continuum in the United States

    Author(s): Gonsalves GS; Paltiel AD; Cleary PD; Gill MJ; Kitahata MM; Rebeiro PF; Silverberg MJ; Horberg M; Abraham AG; Althoff KN; Moore R; Bosch RJ; Hall HI; Kaplan EH

    J Acquir Immune Defic Syndr. 2017 Apr 26.

    PubMed abstract

    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals

    Author(s): Marcus JL; Leyden WA; Chao CR; Horberg MA; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ

    AIDS. 2017 Apr 24;31(7):989-993.

    PubMed abstract

    Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada

    Author(s): Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; D'Souza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS

    J Acquir Immune Defic Syndr. 2017 Apr 07.

    PubMed abstract

    First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013

    Author(s): Wong C; Gange SJ; Buchacz K; Moore RD; Justice AC; Horberg MA; Gill MJ; Koethe JR; Rebeiro PF; Silverberg MJ; Palella FJ; Patel P; Kitahata MM; Crane HM; Abraham AG; Samji H; Napravnik S; Ahmed T; Thorne JE; Bosch RJ; Mayor AM; Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    Clin Infect Dis. 2017 Feb 15;64(4):459-467.

    PubMed abstract

    Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation

    Author(s): Marcus JL; Hurley LB; Hare CB; Nguyen DP; Phengrasamy T; Silverberg MJ; Stoltey JE; Volk JE

    J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546.

    PubMed abstract

    First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013

    Author(s): Wong C; Gange SJ; Buchacz K; Moore RD; Justice AC; Horberg MA; Gill MJ; Koethe JR; Rebeiro PF; Silverberg MJ; Palella FJ; Patel P; Kitahata MM; Crane HM; Abraham AG; Samji H; Napravnik S; Ahmed T; Thorne JE; Bosch RJ; Mayor AM; Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    Clin Infect Dis. 2016 Dec 10.

    PubMed abstract

    Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system

    Author(s): Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP

    Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. Epub 2016-10-14.

    PubMed abstract

    Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics

    Author(s): Satre DD; Altschuler A; Parthasarathy S; Silverberg MJ; Volberding P; Campbell CI

    J Acquir Immune Defic Syndr. 2016 Oct 03.

    PubMed abstract

    Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System

    Author(s): Marcus JL; Hurley LB; Hare CB; Silverberg MJ; Volk JE

    Am J Public Health. 2016 Oct;106(10):e2-3.

    PubMed abstract

    The Effect of HIV Infection, Immunodeficiency and Antiretroviral Therapy on the Risk of Hepatic Dysfunction

    Author(s): Towner WJ; Xu L; Leyden WA; Horberg MA; Chao CR; Tang B; Klein DB; Hurley LB; Quesenberry CP Jr; Silverberg MJ

    J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):321-7.

    PubMed abstract

    Response to Therapy in Antiretroviral Therapy-Na? Patients with Isolated Nonnucleoside Reverse-Transcriptase Inhibitor-Associated Transmitted Drug Resistance

    Author(s): Clutter DS; Fessel WJ; Rhee SY; Hurley LB; Klein DB; Ioannidis JP; Silverberg MJ; Shafer RW

    J Acquir Immune Defic Syndr. 2016 Feb 5.

    PubMed abstract

    Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis

    Author(s): Park LS; Hern?ez-Ram?z RU; Silverberg MJ; Crothers K; Dubrow R

    AIDS. 2016 Jan;30(2):273-91.

    PubMed abstract

    Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America

    Author(s): Rebeiro PF; Althoff KN; Lau B; Gill J; Abraham AG; Horberg MA; Kitahata MM; Yehia BR; Samji H; Brooks JT; Buchacz K; Napravnik S; Silverberg MJ; Rachlis A; Gebo KA; Sterling TR; Moore RD; Gange SJ; North American AIDS Cohort Collaboration on Research and Design

    Am J Epidemiol. 2015 Dec 1;182(11):952-60. Epub 2015-11-17.

    PubMed abstract

    Use of abacavir and risk of cardiovascular disease among HIV-infected individuals

    Author(s): Marcus JL; Neugebauer RS; Leyden WA; Chao CR; Xu L; Quesenberry CP; Klein DB; Towner WJ; Horberg MA; Silverberg MJ

    J Acquir Immune Defic Syndr. 2015 Nov 2.

    PubMed abstract

    The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System

    Author(s): Horberg MA; Hurley LB; Klein DB; Towner WJ; Kadlecik P; Antoniskis D; Mogyoros M; Brachman PS; Remmers CL; Gambatese RC; Blank J; Ellis CG; Silverberg MJ

    AIDS Patient Care STDS. 2015 Nov;29(11):582-90.

    PubMed abstract

    Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study

    Author(s): Silverberg MJ; Lau B; Achenbach CJ; Jing Y; Althoff KN; D'Souza G; Engels EA; Hessol NA; Brooks JT; Burchell AN; Gill MJ; Goedert JJ; Hogg R; Horberg MA; Kirk GD; Kitahata MM; Korthuis PT; Mathews WC; Mayor A; Modur SP; Napravnik S; Novak RM; Patel P; Rachlis AR; Sterling TR; Willig JH; Justice AC; Moore RD; Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS

    Ann Intern Med. 2015 Oct 6;163(7):507-18.

    PubMed abstract

    Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival

    Author(s): Chao C; Xu L; Silverberg MJ; Martinez-Maza O; Chen LH; Castor B; Abrams DI; Zha HD; Haque R; Said J

    AIDS. 2015 Sep 24;29(15):1943-51.

    PubMed abstract

    Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

    Author(s): Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    AIDS Res Hum Retroviruses. 2015 Sep 9.

    PubMed abstract

    Leukoplakia, oral cavity cancer risk, and cancer survival in the U.S. elderly

    Author(s): Yanik EL; Katki HA; Silverberg MJ; Manos MM; Engels EA; Chaturvedi AK

    Cancer Prev Res (Phila). 2015 Jul 9.

    PubMed abstract

    Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV

    Author(s): Saberi P; Catz SL; Leyden WA; Stewart C; Ralston JD; Horberg MA; Grothaus L; Silverberg MJ

    AIDS Behav. 2015 Jun;19 Suppl 2:177-85.

    PubMed abstract

    Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status

    Author(s): Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ

    AIDS Patient Care STDS. 2015 Jul;29(7):370-8. Epub 2015-05-18.

    PubMed abstract

    Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010

    Author(s): Koethe JR; Jenkins CA; Lau B; Shepherd BE; Silverberg MJ; Brown TT; Blashill AJ; Anema A; Willig A; Stinnette S; Napravnik S; Gill J; Crane HM; Sterling TR; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    HIV Med. 2015 May 11.

    PubMed abstract

    Contribution of Demographic and Behavioral Factors on the Changing Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Northern California

    Author(s): Katzel JA; Merchant M; Chaturvedi AK; Silverberg MJ

    Cancer Epidemiol Biomarkers Prev. 2015 May 8.

    PubMed abstract

    Declining Relative Risk for Myocardial Infarction Among HIV-Positive Compared With HIV-Negative Individuals With Access to Care

    Author(s): Klein DB; Leyden WA; Xu L; Chao CR; Horberg MA; Towner WJ; Hurley LB; Marcus JL; Quesenberry CP; Silverberg MJ

    Clin Infect Dis. 2015 Apr 15;60(8):1278-80. Epub 2015-01-16.

    PubMed abstract

    The Impact of Age on Retention in Care and Viral Suppression

    Author(s): Yehia BR; Rebeiro P; Althoff KN; Agwu AL; Horberg MA; Samji H; Napravnik S; Mayer K; Tedaldi E; Silverberg MJ; Thorne JE; Burchell AN; Rourke SB; Rachlis A; Mayor A; Gill MJ; Zinski A; Ohl M; Anastos K; Abraham AG; Kitahata MM; Moore RD; Gebo KA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413-9.

    PubMed abstract

    Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia

    Author(s): Park IU; Wojtal N; Silverberg MJ; Bauer HM; Hurley LB; Manos MM

    PLoS ONE. 2015;10(3):e0118938. Epub 2015-03-20.

    PubMed abstract

    Survival Among HIV-Infected and HIV-Uninfected Individuals with Common Non-AIDS-Defining Cancers

    Author(s): Marcus JL; Chao C; Leyden WA; Xu L; Yu J; Horberg MA; Klein D; Towner WJ; Quesenberry CP; Abrams DI; Silverberg MJ

    Cancer Epidemiol Biomarkers Prev. 2015 Feb 24.

    PubMed abstract

    A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection

    Author(s): Chao C; Silverberg MJ; Xu L; Chen LH; Castor B; Martínez-Maza O; Abrams DI; Zha HD; Haque R; Said J

    Clin Cancer Res. 2015 Mar 15;21(6):1429-37. Epub 2015-01-14.

    PubMed abstract

    End Stage Renal Disease Among HIV-Infected Adults in North America

    Author(s): Abraham AG; Althoff KN; Jing Y; Estrella MM; Kitahata MM; Wester CW; Bosch RJ; Crane H; Eron J; Gill MJ; Horberg MA; Justice AC; Klein M; Mayor AM; Moore RD; Palella FJ; Parikh CR; Silverberg MJ; Golub ET; Jacobson LP; Napravnik S; Lucas GM; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)

    Clin Infect Dis. 2015 Mar 15;60(6):941-9. Epub 2014-11-18.

    PubMed abstract

    Strong agreement of nationally recommended retention measures from the institute of medicine and department of health and human services

    Author(s): Rebeiro PF; Horberg MA; Gange SJ; Gebo KA; Yehia BR; Brooks JT; Buchacz K; Silverberg MJ; Gill J; Moore RD; Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    PLoS ONE. 2014;9(11):e111772. Epub 2014-11-06.

    PubMed abstract

    Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA

    Author(s): Shepherd L; Borges AH; Ravn L; Harvey R; Jean-Paul V; Bower M; Grulich A; Silverberg M; De Wit S; Kirk O; Lundgren J; Mocroft A; EuroSIDA in Eurocoord

    J Int AIDS Soc. 2014;17(4 Suppl 3):19510. Epub 2014-11-02.

    PubMed abstract

    Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals

    Author(s): Beachler DC; Abraham AG; Silverberg MJ; Jing Y; Fakhry C; Gill MJ; Dubrow R; Kitahata MM; Klein MB; Burchell AN; Korthuis PT; Moore RD; D'Souza G; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA

    Oral Oncol. 2014 Dec;50(12):1169-76. Epub 2014-10-06.

    PubMed abstract

    HIV infection and incidence of ischemic stroke

    Author(s): Marcus JL; Leyden WA; Chao CR; Chow FC; Horberg MA; Hurley LB; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ

    AIDS. 2014 Aug 24;28(13):1911-9.

    PubMed abstract

    Prostate Cancer Incidence and Prostate-Specific Antigen Testing Among HIV-Positive and HIV-Negative Men

    Author(s): Marcus JL; Chao CR; Leyden WA; Xu L; Klein DB; Horberg MA; Towner WJ; Quesenberry CP; Abrams DI; Van Den Eeden SK; Silverberg MJ

    J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):495-502.

    PubMed abstract

    Non-AIDS-Defining Malignancies in the HIV-Infected Population

    Author(s): Wang CC; Silverberg MJ; Abrams DI

    Curr Infect Dis Rep. 2014 Jun;16(6):406.

    PubMed abstract

    Immunodeficiency and Risk of Myocardial Infarction Among HIV-Positive Individuals With Access to Care

    Author(s): Silverberg MJ; Leyden WA; Xu L; Horberg MA; Chao CR; Towner WJ; Hurley LB; Quesenberry CP; Klein DB

    J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):160-6.

    PubMed abstract

    Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk

    Author(s): Borges AH; Dubrow R; Silverberg MJ

    Curr Opin HIV AIDS. 2014 Jan;9(1):34-40.

    PubMed abstract

    Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients

    Author(s): Delorenze GN; Horberg MA; Silverberg MJ; Tsai A; Quesenberry CP; Baxter R

    Epidemiol Infect. 2013 Nov;141(11):2392-402. Epub 2013-02-18.

    PubMed abstract

    Missed Office Visits and Risk of Mortality Among HIV-Infected Subjects in a Large Healthcare System in the United States

    Author(s): Horberg MA; Hurley LB; Silverberg MJ; Klein DB; Quesenberry CP; Mugavero MJ

    AIDS Patient Care STDS. 2013 Aug;27(8):442-9. Epub 2013 Jul 19.

    PubMed abstract

    Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

    Author(s): Borges AH; Silverberg MJ; Wentworth D; Grulich AE; Fatkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD; INSIGHT SMART; ESPRIT; SILCAAT Study Groups

    AIDS. 2013 Jun 1;27(9):1433-41.

    PubMed abstract

    Use of web-based shared medical records among patients with HIV

    Author(s): Ralston JD; Silverberg MJ; Grothaus L; Leyden WA; Ross T; Stewart C; Carzasty S; Horberg M; Catz SL

    Am J Manag Care. 2013 Apr;19(4):e114-24. Epub 2013-04-01.

    PubMed abstract

    Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study

    Author(s): Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD; North American AIDS Cohort Collaboration on Research and Design of IeDEA

    J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13.

    PubMed abstract

    HIV Infection Status, Immunodeficiency, and the Incidence of Non-Melanoma Skin Cancer

    Author(s): Silverberg MJ; Leyden W; Warton EM; Quesenberry CP Jr; Engels EA; Asgari MM

    J Natl Cancer Inst. 2013 Mar 6;105(5):350-60. Epub 2013 Jan 4.

    PubMed abstract

    The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer

    Author(s): Habel LA; Ray GT; Silverberg MJ; Horberg MA; Yawn BP; Castillo AL; Quesenberry CP Jr; Li Y; Sadier P; Tran TN

    Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82-90. Epub 2012 Nov 1.

    PubMed abstract

    Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons

    Author(s): Chao C; Leyden WA; Xu L; Horberg MA; Klein D; Towner WJ; Quesenberry CP Jr; Abrams DI; Silverberg MJ

    AIDS. 2012 Nov 13;26(17):2223-31.

    PubMed abstract

    HIV infection, aging, and immune function: implications for cancer risk and prevention

    Author(s): Dubrow R; Silverberg MJ; Park LS; Crothers K; Justice AC

    Curr Opin Oncol. 2012 Sep;24(5):506-16.

    PubMed abstract

    Influence of provider experience on antiretroviral adherence and viral suppression

    Author(s): Horberg MA; Hurley LB; Towner WJ; Allerton MW; Tang BT; Catz SL; Silverberg MJ; Quesenberry CP

    HIV AIDS (Auckl). 2012;4:125-33. Epub 2012 Aug 15.

    PubMed abstract

    Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell lymphoma

    Author(s): Chao C; Silverberg MJ; Martinez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J

    Clin Cancer Res. 2012 Sep 1;18(17):4702-12. Epub 2012 Jun 18.

    PubMed abstract

    Determination of Optimized Multidisciplinary Care Team for Maximal Antiretroviral Therapy Adherence

    Author(s): Horberg MA; Bartemeier Hurley L; James Towner W; Allerton MW; Ting-Ting Tang B; Catz SL; Silverberg MJ; Quesenberry CP

    J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):183-90.

    PubMed abstract

    Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

    Author(s): Silverberg MJ; Lau B; Justice AC; Engels E; Gill MJ; Goedert JJ; Kirk GD; D'Souza G; Bosch RJ; Brooks JT; Napravnik S; Hessol NA; Jacobson LP; Kitahata MM; Klein MB; Moore RD; Rodriguez B; Rourke SB; Saag MS; Sterling TR; Gebo KA; Press N; Martin JN; Dubrow R; the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA

    Clin Infect Dis. 2012 Apr;54(7):1026-34. Epub 2012 Jan 30.

    PubMed abstract

    Prescription Long-term Opioid Use in HIV-infected Patients

    Author(s): Silverberg MJ; Ray GT; Saunders K; Rutter CM; Campbell CI; Merrill JO; Sullivan MD; Von Korff M; Weisner C; Banta-Green CJ

    Clin J Pain. 2012 Jan;28(1):39-46.

    PubMed abstract

    HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer

    Author(s): Silverberg MJ; Chao C; Leyden WA; Xu L; Horberg MA; Klein D; Towner WJ; Dubrow R; Quesenberry CP Jr; Neugebauer RS; Abrams DI

    Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9. Epub 2011 Nov 22.

    PubMed abstract

    Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening

    Author(s): Sterling TR; Lau B; Zhang J; Freeman A; Bosch RJ; Brooks JT; Deeks SG; French A; Gange S; Gebo KA; John Gill M; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Klein MB; Martin JN; Rodriguez B; Silverberg MJ; Willig JH; Eron JJ; Goedert JJ; Hogg RS; Justice AC; McKaig RG; Napravnik S; Thorne J; Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)

    J Infect Dis. 2011 Sep 15;204(6):893-901.

    PubMed abstract

    HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons

    Author(s): Chao C; Xu L; Abrams DI; Towner WJ; Horberg MA; Leyden WA; Silverberg MJ

    AIDS. 2011 Sep 10;25(14):1771-7.

    PubMed abstract

    Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america

    Author(s): Abraham AG; Lau B; Deeks S; Moore RD; Zhang J; Eron J; Harrigan R; Gill MJ; Kitahata M; Klein M; Napravnik S; Rachlis A; Rodriguez B; Rourke S; Benson C; Bosch R; Collier A; Gebo K; Goedert J; Hogg R; Horberg M; Jacobson L; Justice A; Kirk G; Martin J; McKaig R; Silverberg M; Sterling T; Thorne J; Willig J; Gange SJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS

    Am J Epidemiol. 2011 Sep 15;174(6):727-35. Epub 2011 Aug 3.

    PubMed abstract

    Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus

    Author(s): Saberi P; Ranatunga DK; Quesenberry CP; Silverberg MJ

    Pharmacotherapy. 2011 Mar;31(3):253-61.

    PubMed abstract

    HIV quality performance measures in a large integrated health care system

    Author(s): Horberg M; Hurley L; Towner W; Gambatese R; Klein D; Antoniskis D; Weinberg W; Kadlecik P; Remmers C; Dobrinich R; Quesenberry C; Silverberg M; Johnson M

    AIDS Patient Care STDS. 2011 Jan;25(1):21-8.

    PubMed abstract

    CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

    Author(s): Althoff KN; Gebo KA; Gange SJ; Klein MB; Brooks JT; Hogg RS; Bosch RJ; Horberg MA; Saag MS; Kitahata MM; Eron JJ; Napravnik S; Rourke SB; Gill MJ; Rodriguez B; Sterling TR; Deeks SG; Martin JN; Jacobson LP; Kirk GD; Collier AC; Benson CA; Silverberg MJ; Goedert JJ; McKaig RG; Thorne J; Rachlis A; Moore RD; Justice AC; for the North American AIDS Cohort Collaboration on Research and Design

    AIDS Res Ther. 2010 Dec 15;7:45.

    PubMed abstract

    Age and gender trends in long-term opioid analgesic use for noncancer pain

    Author(s): Campbell CI; Weisner C; Leresche L; Ray GT; Saunders K; Sullivan MD; Banta-Green CJ; Merrill JO; Silverberg MJ; Boudreau D; Satre DD; Von Korff M

    Am J Public Health. 2010 Dec;100(12):2541-7. Epub 2010 Aug 19.

    PubMed abstract

    Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy

    Author(s): Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M

    AIDS. 2010 Jul 17;24(11):1765-70.

    PubMed abstract

    Late presentation for human immunodeficiency virus care in the United States and Canada

    Author(s): Althoff KN; Gange SJ; Klein MB; Brooks JT; Hogg RS; Bosch RJ; Horberg MA; Saag MS; Kitahata MM; Justice AC; Gebo KA; Eron JJ; Rourke SB; Gill MJ; Rodriguez B; Sterling TR; Calzavara LM; Deeks SG; Martin JN; Rachlis AR; Napravnik S; Jacobson LP; Kirk GD; Collier AC; Benson CA; Silverberg MJ; Kushel M; Goedert JJ; McKaig RG; Van Rompaey SE; Zhang J; Moore RD

    Clin Infect Dis. 2010 Jun 1;50(11):1512-20.

    PubMed abstract

    Opioid prescriptions for chronic pain and overdose: a cohort study

    Author(s): Dunn KM; Saunders KW; Rutter CM; Banta-Green CJ; Merrill JO; Sullivan MD; Weisner CM; Silverberg MJ; Campbell CI; Psaty BM; Von Korff M

    Ann Intern Med. 2010 Jan 19;152(2):85-92.

    PubMed abstract

    Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California

    Author(s): Horberg MA; Ranatunga DK; Quesenberry CP; Klein DB; Silverberg MJ

    Sex Transm Dis. 2010 Jan;37(1):53-8.

    PubMed abstract

    Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients

    Author(s): Horberg M; Tang B; Towner W; Silverberg M; Bersoff-Matcha S; Hurley L; Chang J; Blank J; Quesenberry C Jr; Klein D

    J Acquir Immune Defic Syndr. 2010 Jan 1;53(1):62-9.

    PubMed abstract

    Trends in long-term opioid therapy for chronic non-cancer pain

    Author(s): Boudreau D; Von Korff M; Rutter CM; Saunders K; Ray GT; Sullivan MD; Campbell CI; Merrill JO; Silverberg MJ; Banta-Green C; Weisner C

    Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166-75.

    PubMed abstract

    Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

    Author(s): Deeks SG; Gange SJ; Kitahata MM; Saag MS; Justice AC; Hogg RS; Eron JJ; Brooks JT; Rourke SB; Gill MJ; Bosch RJ; Benson CA; Collier AC; Martin JN; Klein MB; Jacobson LP; Rodriguez B; Sterling TR; Kirk GD; Napravnik S; Rachlis AR; Calzavara LM; Horberg MA; Silverberg MJ; Gebo KA; Kushel MB; Goedert JJ; McKaig RG; Moore RD

    Clin Infect Dis. 2009 Nov 15;49(10):1582-90.

    PubMed abstract

    HIV infection and the risk of cancers with and without a known infectious cause

    Author(s): Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP Jr; Towner WJ; Abrams DI

    AIDS. 2009 Nov 13;23(17):2337-45.

    PubMed abstract

    Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care

    Author(s): Silverberg MJ; Leyden W; Quesenberry CP Jr; Horberg MA

    J Gen Intern Med. 2009 Sep;24(9):1065-72. Epub 2009 Jul 16.

    PubMed abstract

    Increased rates of appendicitis in HIV-infected men: 1991-2005

    Author(s): Klein DB; Hurley LB; Horberg MA; Silverberg MJ; Follansbee SE; Flamm JA; Green GM

    J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):139-40.

    PubMed abstract

    Trends in long-term opioid therapy for noncancer pain among persons with a history of depression

    Author(s): Braden JB; Sullivan MD; Ray GT; Saunders K; Merrill J; Silverberg MJ; Rutter CM; Weisner C; Banta-Green C; Campbell C; Von Korff M

    Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):564-70. Epub 2009 Aug 27.

    PubMed abstract

    Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy

    Author(s): Silverberg MJ; Jacobson LP; French AL; Witt MD; Gange SJ

    J Pain Symptom Manage. 2009 Aug;38(2):197-207. Epub 2009 Mar 28.

    PubMed abstract

    Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders

    Author(s): Weisner CM; Campbell CI; Ray GT; Saunders K; Merrill JO; Banta-Green C; Sullivan MD; Silverberg MJ; Mertens JR; Boudreau D; Von Korff M

    Pain. 2009 Oct;145(3):287-93. Epub 2009 Jul 5.

    PubMed abstract

    Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection

    Author(s): Silverberg MJ; Leyden W; Hurley L; Go AS; Quesenberry CP Jr; Klein D; Horberg MA

    Ann Intern Med. 2009 Mar 3;150(5):301-13.

    PubMed abstract

    Smoking enhances risk for new external genital warts in men

    Author(s): Wiley DJ; Elashoff D; Masongsong EV; Harper DM; Gylys KH; Silverberg MJ; Cook RL; Johnson-Hill LM

    Int J Environ Res Public Health. 2009 Mar;6(3):1215-34. Epub 2009 Mar 20.

    PubMed abstract

    Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

    Author(s): Silverberg MJ; Abrams D

    Curr Opin HIV AIDS. 2009 Jan;4(1):42-51.

    PubMed abstract

    Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naive patients

    Author(s): Horberg M; Klein D; Hurley L; Silverberg M; Towner W; Antoniskis D; Kovach D; Mogyoros M; Blake W; Dobrinich R; Dodge W

    HIV Clin Trials. 2008 Nov-Dec;9(6):367-74.

    PubMed abstract

    De facto long-term opioid therapy for noncancer pain

    Author(s): Korff MV; Saunders K; Thomas Ray G; Boudreau D; Campbell C; Merrill J; Sullivan MD; Rutter CM; Silverberg MJ; Banta-Green C; Weisner C

    Clin J Pain. 2008 Jul-Aug;24(6):521-7.

    PubMed abstract

    Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens

    Author(s): Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C

    AIDS Patient Care STDS. 2008 Apr;22(4):301-12.

    PubMed abstract

    AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era

    Author(s): Silverberg MJ; Abrams DI

    Curr Opin Oncol. 2007 Sep;19(5):446-51.

    PubMed abstract

    Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy

    Author(s): Horberg MA; Hurley LB; Silverberg MJ; Kinsman CJ; Quesenberry CP

    J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):531-9.

    PubMed abstract

    Older age and the response to and tolerability of antiretroviral therapy

    Author(s): Silverberg MJ; Leyden W; Horberg MA; DeLorenze GN; Klein D; Quesenberry CP Jr

    Arch Intern Med. 2007 Apr 9;167(7):684-91.

    PubMed abstract

    Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

    Author(s): Silverberg MJ; Schneider MF; Silver B; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine AM; Viscidi RP

    Clin Vaccine Immunol. 2006 Apr;13(4):511-9.

    PubMed abstract